Eastman Chemical (EMN)
(Delayed Data from NYSE)
$109.27 USD
+0.27 (0.25%)
Updated Oct 7, 2024 04:00 PM ET
After-Market: $109.30 +0.03 (0.03%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth B Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$109.27 USD
+0.27 (0.25%)
Updated Oct 7, 2024 04:00 PM ET
After-Market: $109.30 +0.03 (0.03%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth B Momentum B VGM
Zacks News
Earnings Preview: Eastman Chemical (EMN) Q4 Earnings Expected to Decline
by Zacks Equity Research
Eastman Chemical (EMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Is Cabot (CBT) Up 2% Since Last Earnings Report?
by Zacks Equity Research
Cabot (CBT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Kronos Worldwide (KRO) Up 3.5% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Kronos Worldwide (KRO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Is FMC (FMC) Up 9% Since Last Earnings Report?
by Zacks Equity Research
FMC (FMC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Eastman Chemical's (EMN) Q3 Earnings & Sales Top Estimates
by Zacks Equity Research
Eastman Chemical (EMN) benefits from actions to improve mix with innovative products and implement price hikes to counter cost inflation in Q3.
Eastman Chemical (EMN) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Eastman Chemical (EMN) delivered earnings and revenue surprises of 2.50% and 5.52%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Methanex (MEOH) Misses Q3 Earnings Estimates
by Zacks Equity Research
Methanex (MEOH) delivered earnings and revenue surprises of -15.85% and 3.09%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: FMC (FMC) Q3 Earnings Expected to Decline
by Zacks Equity Research
FMC (FMC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Eastman Chemical (EMN) to Post Q3 Earnings: Factors at Play
by Zacks Equity Research
Eastman Chemical (EMN) is likely to have gained from pricing and cost actions amid headwinds from higher raw material, energy and distribution costs in Q3.
Albemarle (ALB) Gains on Strong Demand, Capacity Expansion
by Zacks Equity Research
Albemarle (ALB) rides on strong demand and prices in its lithium and bromine businesses.
Analysts Estimate Eastman Chemical (EMN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Eastman Chemical (EMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stepan Co. (SCL) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Stepan Co. (SCL) delivered earnings and revenue surprises of 24.84% and 8.23%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Is the Options Market Predicting a Spike in Eastman Chemical (EMN) Stock?
by Zacks Equity Research
Investors need to pay close attention to Eastman Chemical (EMN) stock based on the movements in the options market lately.
Here's Why You Should Hold Eastman Chemical (EMN) for Now
by Zacks Equity Research
While Eastman Chemical (EMN) faces headwinds from higher input and logistics costs, it benefits from productivity actions, strong demand and innovation.
Eastman (EMN) & Interzero Ink Supply Deal for Recycling Plant
by Zacks Equity Research
Under the deal, Interzero will provide up to 20,000 metric tons annually of hard-to-recycle PET household packaging waste for Eastman Chemical's (EMN) facility in France.
Air Products (APD) Gains on Project Investments, Productivity
by Zacks Equity Research
Air Products (APD) is well-placed to gain from its investments in high-return industrial gas projects, project wins and efforts to boost productivity amid headwinds from higher costs.
Company News for Sep 14, 2022
by Zacks Equity Research
Companies in The News Are: CNM, NVDA, ORCL, EMN
Air Products (APD) Gains on Project Investments, Productivity
by Zacks Equity Research
Air Products (APD) is well-placed to gain from its investments in high-return industrial gas projects, project wins and efforts to boost productivity amid headwinds from higher costs.
Eastman Chemical's (EMN) Q2 Earnings & Sales Top Estimates
by Zacks Equity Research
Eastman Chemical's (EMN) Q2 results are driven by higher selling prices across all segments.
Eastman Chemical (EMN) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Eastman Chemical (EMN) delivered earnings and revenue surprises of 5.20% and 1.14%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
LyondellBasell (LYB) to Post Q2 Earnings: What's in the Cards?
by Zacks Equity Research
LyondellBasell's (LYB) Q2 performance is likely to have benefited from strong consumer-driven demand and favorable market trends.
Are You Looking for a High-Growth Dividend Stock?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Eastman Chemical (EMN) have what it takes? Let's find out.
Stepan Co. (SCL) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Stepan Co. (SCL) delivered earnings and revenue surprises of 21.05% and 8.56%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Westlake (WLK) to Post Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Westlake (WLK) is likely to have witnessed strong demand and pricing for PVC resin in Q2 on the back of continued strength in the residential construction market.
Analysts Estimate DuPont de Nemours (DD) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
DuPont de Nemours (DD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.